Men | Women | |
---|---|---|
Participation; % | 63.7 | 69.3 |
Colonoscopy compliance; % | 95.0 | 94.2 |
Total number of participantsa | 10,982 | 7291 |
Colorectal cancer (CRC) | 693 | 339 |
Age (years); mean (SD) | 61.4 (5.1) | 60.2 (5.6) |
μg Hb/g faeces; median (IQR) | 219.0 (74.2–694.5)) | 175.3 (63.8–440.8) |
Location Location (proximal side/distal side/rectum)b; % | 18.2/70.1/11.7 | 21.8/64.2/14.0 |
Stage (I-II/III-IV/missing); % | 68.0/27.6/4.4 | 63.7/30.8/5.5 |
Size (cm); mean (SD) | 2.7 (1.5) | 2.8 (1.6) |
Advanced adenomas (AA)c | 5188 | 2028 |
Age (years); mean (SD) | 60.1 (5.4) | 59.8 (5.6) |
μg Hb/g faeces; median (IQR) | 79.2 (35.2–229.6) | 71.6 (33.2–188.6) |
Location Location (proximal side/distal side/rectum)b; % | 20.1/67.4/12.5 | 20.1/63.7/16.2 |
Number polyps; median (IQR) | 3.0 (2.0–5.0) | 2.0 (1.0–4.0) |
Higher size polyps (mm); median (IQR) | 12.0 (9.0) | 12.0 (8.0) |
Size of AA >9 mm; % | 65.1 | 65.1 |
Size of AA >19 mm; % | 13.6 | 12.8 |
AA with villous component; % | 36.2 | 36.3 |
AA with severe/high-grade dysplasia; % | 8.6 | 8.7 |